ILiAD Biotechnologies
Biotechnology company focused on the prevention and treatment of disease caused by bordetella pertussis.
Launch date
Employees
Market cap
-
Enterprise valuation
€156—233m (Dealroom.co estimates Sep 2022.)
Weston Florida (HQ)
Authorizing premium user...